VIA
REGN icon

Vident Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,634
Closed -$11.2M 806
2023
Q2
$11.2M Sell
15,634
-4,650
-23% -$3.34M 0.39% 60
2023
Q1
$16.7M Buy
20,284
+1,679
+9% +$1.38M 0.54% 31
2022
Q4
$13.4M Buy
18,605
+9,755
+110% +$7.04M 0.51% 32
2022
Q3
$5.79M Sell
8,850
-9,897
-53% -$6.48M 0.19% 147
2022
Q2
$11.1M Buy
18,747
+9,768
+109% +$5.78M 0.33% 66
2022
Q1
$6.27M Sell
8,979
-4,634
-34% -$3.24M 0.16% 146
2021
Q4
$8.6M Sell
13,613
-2,355
-15% -$1.49M 0.22% 89
2021
Q3
$9.66M Buy
15,968
+3,100
+24% +$1.88M 0.29% 66
2021
Q2
$7.19M Sell
12,868
-1,640
-11% -$916K 0.22% 78
2021
Q1
$6.86M Buy
14,508
+4,834
+50% +$2.29M 0.23% 76
2020
Q4
$4.67M Buy
9,674
+1,419
+17% +$685K 0.19% 90
2020
Q3
$4.62M Buy
8,255
+493
+6% +$276K 0.23% 87
2020
Q2
$4.84M Buy
7,762
+10
+0.1% +$6.24K 0.25% 78
2020
Q1
$3.79M Buy
7,752
+3,276
+73% +$1.6M 0.25% 77
2019
Q4
$1.68M Sell
4,476
-443
-9% -$166K 0.1% 301
2019
Q3
$1.36M Sell
4,919
-169
-3% -$46.9K 0.12% 129
2019
Q2
$1.59M Buy
5,088
+655
+15% +$205K 0.13% 110
2019
Q1
$1.82M Sell
4,433
-88
-2% -$36.1K 0.1% 309
2018
Q4
$1.69M Buy
4,521
+3,209
+245% +$1.2M 0.09% 293
2018
Q3
$530K Sell
1,312
-402
-23% -$162K 0.02% 670
2018
Q2
$591K Sell
1,714
-279
-14% -$96.2K 0.02% 598
2018
Q1
$637K Sell
1,993
-175
-8% -$55.9K 0.03% 512
2017
Q4
$815K Buy
2,168
+1,720
+384% +$647K 0.04% 412
2017
Q3
$200K Buy
+448
New +$200K 0.01% 716
2015
Q3
Sell
-10
Closed -$5K 1136
2015
Q2
$5K Buy
+10
New +$5K ﹤0.01% 1016